These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28371465)

  • 1. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
    Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
    Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
    Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A
    Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
    Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
    Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
    Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of the Paris System for veterans: high rates of undiagnosed low-grade urothelial neoplasia.
    Chandler JB; Colunga M; Celli R; Lithgow MY; Baldassarri RJ
    J Am Soc Cytopathol; 2021; 10(4):357-365. PubMed ID: 33849782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
    Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
    Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
    Richardson CJ; Pambuccian SE; Barkan GA
    Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
    Straccia P; Bizzarro T; Fadda G; Pierconti F
    Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
    Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
    Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
    Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
    Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation study of the Paris system for reporting urinary (TPS) categories.
    Pierconti F; Martini M; Cenci T; Fiorentino V; Sacco E; Bientinesi R; Pugliese D; Iacovelli R; Schinzari G; Larocca LM; Bassi PF
    J Clin Pathol; 2021 Feb; 74(2):102-105. PubMed ID: 32527754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical application of the Paris system for reporting urinary cytology].
    Chen L; Liu LT; Sun MJ; He SR; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328
    [No Abstract]   [Full Text] [Related]  

  • 20. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
    Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
    Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.